You just read:

Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology

News provided by

Bausch Health Companies Inc.

Oct 11, 2018, 08:00 ET